Skip to main content

Wendel announces the entry into a prepaid 3-year forward sale of Bureau Veritas shares representing 6.7% of share capital, together with an option to retain partial share price upside, and increases its financial flexibility by redu

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW Wendel announces the entry into a prepaid 3-year forward sale of Bureau Veritas shares representing 6.7% of share capital, together with an option to retain partial share price upside, and increases its financial flexibility by reducing the pro forma1 loan-to-value ratio to c.17% Wendel to retain 26.5% of the share capital and 41.2% of voting rights of Bureau Veritas Wendel today announces that it has entered into a prepaid 3-year forward sale agreement with BNP Paribas (the “Forward Bank“) (subject to the effective completion of the Offering as described below) for 30,357,140 shares2 (representing...

Continue reading

WNC & Associates and Belmont Development Company Acquire Three Affordable Housing Communities in Le Flore County, Oklahoma

$10.9 Million Development to Preserve 80 Affordable UnitsThe office building located at the GardenWalk of PocArk – Arkoma propertyWNC & Associates (WNC) and Belmont Development Company (BDC) have closed a deal to acquire three affordable housing properties, GardenWalk of Pocola, GardenWalk of PocArk – Pocola and GardenWalk of PocArk – Arkoma, in Arkoma and Pocola, Oklahoma.ARKOMA, Okla. and POCOLA, Okla., March 11, 2025 (GLOBE NEWSWIRE) — WNC & Associates (WNC), a family-owned business known as both a pioneer and leader in the affordable housing industry, and Belmont Development Company (BDC), an Oklahoma-based developer with expertise in affordable housing through USDA-Rural Development and Low-Income Housing Tax Credits (LIHTC), have closed a deal to acquire three affordable housing properties,...

Continue reading

H.I.G. Capital Completes Acquisition of Quisitive

TORONTO, March 11, 2025 (GLOBE NEWSWIRE) — Quisitive Technology Solutions, Inc. (“Quisitive” or the “Company”) (TSXV: QUIS; OTCQX: QUISF), a premier Microsoft Cloud and AI solutions provider, is pleased to announce the successful completion of the previously announced plan of arrangement under the Business Corporations Act (British Columbia) (the “Transaction”) pursuant to which, among other things, an affiliate of funds managed by of H.I.G. Capital (the “Purchaser”) acquired all of the issued and outstanding common shares of Quisitive (the “Shares”) for C$0.57 per Share in cash, other than Shares previously held by certain employees who entered into rollover agreements. The Company received the final order from the Supreme Court of British Columbia approving the Transaction on March 4, 2025, and the Shares are expected to be delisted...

Continue reading

Better Choice Company Signs Binding Letter of Intent to Acquire Choice Specialty Pharmacy, Expanding U.S. Presence

TAMPA, Fla., March 11, 2025 (GLOBE NEWSWIRE) — Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced that it has signed a binding Letter of Intent (LOI) to acquire 100% of Choice Specialty Pharmacy Group (“Seller”), a fully licensed and prominent provider of specialized pharmacy services in the U.S., through an option purchase agreement. This acquisition is expected to further strengthen Better Choice’s specialty pharmacy presence in the U.S. and the purchase price is based on 6X of Seller’s FY2024 Adjusted EBITDA1 of approximately USD $4.68 million1, and consideration will be comprised of stock and cash at closing. “With the addition of Choice Specialty Pharmacy Group alongside our SRx platform in Canada, we are now executing on our...

Continue reading

Medera Completes Patient Dosing in Phase 1/2a MUSIC-HFrEF Trial of SRD-001 Gene Therapy for Heart Failure with Reduced Ejection Fraction

BOSTON, March 11, 2025 (GLOBE NEWSWIRE) — Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics, today announced that patient dosing has been completed in its MUSIC-HFrEF Phase 1/2a clinical trial of the gene therapy candidate SRD-001 in patients with heart failure with reduced ejection fraction (HErEF). HErEF is a prevalent form of heart disease that accounts for half of an estimated 64.3 million heart failure cases worldwide and is currently considered a mass market incurable disease. The MUSIC-HFrEF trial is an open-label, uncontrolled study investigating SRD-001 across two cohorts with six patients dosed with SRD-001 in Cohort A (low-dose 3×1013 vg per patient) and three patients dosed...

Continue reading

zSpace Acquires BlocksCAD to Revolutionize 3D Design and STEM Education

Strategic acquisition expands zSpace’s immersive learning solutions with BlocksCAD’s 3D design platform for STEM education SAN JOSE, Calif., March 11, 2025 (GLOBE NEWSWIRE) — zSpace (NASDAQ: ZSPC), a leader in augmented and virtual reality (AR/VR) education, today announced the acquisition of BlocksCAD, a cutting-edge platform specializing in 3D design and modeling for STEM education. The acquisition strengthens zSpace’s commitment to transforming education through innovative technology and expands its capabilities to deliver engaging, hands-on learning experiences for students worldwide. BlocksCAD’s intuitive design platform empowers students and educators to explore coding, mathematics, and engineering concepts through 3D modeling and design. By integrating BlocksCAD’s powerful tools into zSpace’s immersive learning ecosystem,...

Continue reading

StoneX to Acquire The Benchmark Company, Adding Capabilities in Investment Banking

NEW YORK, March 11, 2025 (GLOBE NEWSWIRE) — StoneX Group Inc. (the “Company”; NASDAQ: SNEX) has signed an agreement to acquire The Benchmark Company, LLC (“Benchmark”). This strategic acquisition will strengthen StoneX’s offerings in equity and debt capital markets, with significant enhancements in equity research and investment banking. The Benchmark Company is a full-service investment banking firm offering a robust sales and trading platform, award-winning equity research, and a highly experienced investment banking team. Headquartered in New York City and operating nationwide, Benchmark has been delivering exceptional client service, market access, and deep market and industry expertise for over 35 years. Richard Messina, Founder and CEO of Benchmark, will continue in his role, leading the division within StoneX. Jacob Rappaport,...

Continue reading

Form 8.3 – [ALLIANCE PHARMA PLC – 10 03 2025] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ALLIANCE PHARMA PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

ZenaTech Signs LOI to Acquire Sixth Land Survey Company in Arizona and First in the Southwest Region for Drone as a Service

VANCOUVER, British Columbia, March 11, 2025 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology company specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS and Quantum Computing solutions, announces that it has signed an LOI (Letter of Intent) to acquire a sixth land survey engineering company located in Arizona. Upon completion, this will be the first acquisition in the Southwest Region and will serve as a launchpad to further regional development and the Company’s national DaaS business model bringing the speed and precision of AI drone solutions in a convenient subscription or pay-per-use model for businesses and government users. “Arizona is a strategic location for our first potential Southwest region acquisition as we currently...

Continue reading

Form 8.3 – [LEARNING TECHNOLOGIES GROUP PLC – 10 03 2025] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree LEARNING TECHNOLOGIES GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.